Results 121 to 130 of about 137,068 (205)

Cannabis Use Disorder Is Associated With Increased Risk of Acute Myocardial Infarction in Adults With Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: A Population-Based Analysis. [PDF]

Cureus
Njei B, Boateng S, Kwentoh I, Ameyaw P, Ezeani C, Nso N, Forsah S, Dimala CA, Ugwendum DF, Njei LP, Al-Ajlouni YA, Lim JK, Dranoff JA.   +12 more
europepmc   +1 more source

Individualized Evaluation on Suspicion of Fibrotic Metabolic-Dysfunction-Associated Steatohepatitis: Real-World Experience from a Referral Center in Denmark. [PDF]

J Pers Med
Dahl EE, Willemoe GL, Berner-Hansen M, Schiødt FV.   +3 more
europepmc   +1 more source

Steatohepatitis Mechanisms [PDF]

Hepatology, 2013
openaire   +1 more source

Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients. [PDF]

Hepatobiliary Surg Nutr
Kim SK, An HS, Roh GS.
europepmc   +1 more source

Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment. [PDF]

Diabetes Obes Metab
Romanos M, Garcia Cordova JM, Villamarin J, Pazmino Zurita JD, Acosta A.   +4 more
europepmc   +1 more source

Impact of liver cirrhosis etiology on results of diagnostic tests for minimal hepatic encephalopathy. [PDF]

Sci Rep
Egge JFM, Ehrenbauer AF, Gabriel MM, Tiede A, Al-Ayoubi J, Witt J, Mauz JB, Kabelitz MA, Wagner LS, Wedemeyer H, Grosshennig A, Grosse GM, Maasoumy B, Weissenborn K.   +13 more
europepmc   +1 more source

Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population. [PDF]

Gastro Hep Adv
van Kleef LA, Michel M, Savas M, Pustjens J, Theel W, van Rossum EFC, Paik JM, Younossi ZM, Janssen HLA, Labenz C, Schattenberg JM, Brouwer WP.   +11 more
europepmc   +1 more source

Ironing out Steatohepatitis

Annals of Hepatology, 2017
openaire   +4 more sources